This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
HIV Infections
and you are
between 18 and 50
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This trial will study a prime-boost vaccine approach designed mainly to induce cell-mediated immune (CTL) responses.

Provided treatments

  • Biological: ADVAX
  • Biological: TBC-M4
  • Other: Placebo
Tris trial is registered with FDA with number: NCT00902824. The sponsor of the trial is International AIDS Vaccine Initiative and it is looking for 32 volunteers for the current phase.
Official trial title:
Phase I Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of TBC-M4 (MVA Based HIV Vaccine) Alone or in a Prime-Boost Regimen With ADVAX, DNA HIV Vaccine